Navigation Links
Group Florence Nightingale Increases Radiosurgery Profile with Acquisition of Turkey's First Leksell Gamma Knife Perfexion System
Date:9/19/2012

ISTANBUL, Sept. 19, 2012 /PRNewswire/ -- Leksell Gamma Knife® Perfexion™ – Elekta's most advanced Gamma Knife® platform – became Turkey's fifth Gamma Knife system, beginning clinical operation at Group Florence Nightingale's Comprehensive Cancer Center (Istanbul) on May 25. The Cancer Center's Prof. Dr. Talat Kiris used Perfexion for the first time by treating a 15-year-old Iraqi boy with a partially resected skull base tumor.

Gamma Knife radiosurgery is a patient friendly alternative to traditional brain surgery for illnesses such as metastatic disease, arteriovenous malformations (AVM) and meningiomas. With pinpoint accuracy, the system delivers up to thousands of low-intensity radiation beams to one or more targets in a single session. Perfexion provides even greater speed and ease of use than previous models.

According to Prof. Dr. Kiris, both he and the Group's administration were strongly committed to acquiring Perfexion for the Comprehensive Cancer Center due to the proven effectiveness of Gamma Knife surgery and to the added sophistication of the Perfexion system.

"For years, Gamma Knife surgery has the accepted gold standard for the treatment of many intracranial indications," Prof. Dr. Kiris observes. "In addition, compared to previous Gamma Knife models, Perfexion dramatically streamlines the radiosurgery workflow and expands the treatable volume with a new collimator. Treatment delivery to one or more tumors in a single session also is greatly facilitated in Perfexion, and allows treatment of a wider range of targets faster, more efficiently and safer than before.

"For me, Perfexion is a neurosurgeon's tool," he continues. "It's very easy to use and if you know brain anatomy very well, the system software helps you a lot."

First clinical cases successful

The first Perfexion case involving the boy from Iraq was unusual, he says.

"It was a highly vascular lesion that bled significantly during resection, so we stopped the surgery, leaving part of it intact. He had radiosurgery with Perfexion and everything went perfectly. He flew back to his country the next morning."

The second Perfexion patient came the very same day, a Bulgarian man with a vestibular schwannoma, a common Gamma Knife radiosurgery indication. This patient also left the hospital on the day of his surgery. Since then, eight other private patients – encompassing an AVM and a metastasis, meningiomas and trigeminal neuralgia – have undergone Perfexion radiosurgery.

"On July 5, we treated a patient with a brain stem tumor from Azerbaijan and the following week we treated two more patients, one with an AVM and one with a vestibular schwannoma," he notes. "Next year, I predict we will treat increasing numbers of patients with one or more metastases."

For further information, please contact:
Johan Andersson Melbi, Investor Relations Manager, Elekta AB
Tel: +46 702 100 451, email: johan.anderssonmelbi@elekta.com  
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
3. Watson to Acquire Actavis Group for EUR4.25 Billion
4. CentraState and Freehold Radiology Group train physicians from China
5. Winner Medical Group Inc. to Host Second Quarter 2012 Earning Conference Call on Thursday, May 10, 2012 at 9:00 p.m. EDT
6. Okuma America Chooses The Daniel Group To Provide Customer Service Research
7. H. D. Smith Signs Three Year Prime Vendor Agreement with PharmacyGPO Buying Group
8. PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor
9. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
10. New Report Outlines Use of Innovative Marketing to Engage Customer Groups that are Key to the Pharmaceutical Industry
11. IntelligentMDx Announces CE-Marking of a new high-throughput test for Group B Streptococcus intended to improve womens health and prenatal care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
(Date:5/26/2016)... May 26, 2016   Change Healthcare ... analytics, network solutions and technology-enabled services designed ... entered into a strategic channel partnership with ... software solutions and revenue cycle management services ... and rehabilitation clinics to optimize revenue, operational ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, 2016 ... ; Frankfurt Prime Standard: QIA) today announced that the company ... Diagnostics GmbH to develop and commercialize predictive assays in oncology. ... as a marker to predict effectiveness of anthracycline treatment in ... "We are pleased to partner with Therawis, which developed the ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 2016 , ... This campaign aims to provide a path to improved education ... control and change. , As nearly 795,000 Americans suffering from a new or recurrent ... Plus, with an estimated 129,000 of these people dying from stroke, it’s become our ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... Mediaplanet to help educate the many who are unaware of the plight of ... aphasia will run within the “Stroke Awareness” campaign. , The link between stroke ...
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in ... courtesy of leaders in the nursing and health care industry. It also provides ... and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is adding ...
(Date:5/27/2016)... ... May 27, 2016 , ... Each year Standard ... Allison Outerbridge is this year’s Life University winner of a $2,500 ... university’s Student Leadership Awards ceremony. , Outerbridge is approaching her last quarter at ...
(Date:5/26/2016)... ... , ... Despite last week’s media reports hinting at a June rate hike ... March 2017 for an interest rate increase, according to Rajeev Dhawan of the Economic ... Federal Open Market Committee (FOMC) dot charts are of interest to the press for ...
Breaking Medicine News(10 mins):